Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2015 (2015), Article ID 839152, 9 pages
http://dx.doi.org/10.1155/2015/839152
Research Article

Awareness of Prediabetes and Diabetes among Persons with Clinical Depression

1New York University College of Nursing, New York, NY 10010, USA
2NYU Langone Medical Center, New York, NY 10016, USA

Received 19 November 2014; Accepted 3 April 2015

Academic Editor: Javier Salvador

Copyright © 2015 Mary Rosedale et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Centers for Disease Control and Prevention, “National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States,” 2013, http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf.
  2. M. I. Harris, R. Klein, T. A. Welborn, and M. W. Knuiman, “Onset of NIDDM occurs at least 4–7 yr before clinical diagnosis,” Diabetes Care, vol. 15, no. 7, pp. 815–819, 1992. View at Publisher · View at Google Scholar · View at Scopus
  3. M. I. Harris and R. C. Eastman, “Early detection of undiagnosed diabetes mellitus: a US perspective,” Diabetes/Metabolism Research and Reviews, vol. 16, no. 4, pp. 230–236, 2000. View at Google Scholar · View at Scopus
  4. M. E. Ryan, “Diagnostic & therapeutic strategies for the management of the diabetic patient,” Compendium of Continuing Education in Dentistry, vol. 29, no. 1, pp. 32–38, 40–44, 2008. View at Google Scholar
  5. V. A. Fonseca, “Identification and treatment of prediabetes to prevent progression to type 2 diabetes,” Clinical Cornerstone, vol. 8, no. 2, pp. 10–20, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. Diabetes Prevention Program Research Group, “Support for lifestyle changes: a key to success in diabetes prevention,” Diabetes Spectrum, vol. 20, pp. 205–209, 2000. View at Google Scholar
  7. C. J. Sumner, S. Sheth, J. W. Griffin, D. R. Cornblath, and M. Polydefkis, “The spectrum of neuropathy in diabetes and impaired glucose tolerance,” Neurology, vol. 60, no. 1, pp. 108–111, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Polydefkis, J. W. Griffin, and J. McArthur, “New insights into diabetic polyneuropathy,” The Journal of the American Medical Association, vol. 290, no. 10, pp. 1371–1376, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. W. H. Herman, Y. Ma, G. Uwaifo et al., “Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the diabetes prevention program,” Diabetes Care, vol. 30, no. 10, pp. 2453–2457, 2007. View at Google Scholar
  10. E. Barrett-Connor and A. Ferrara, “Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men: the Rancho Bernardo study,” Diabetes Care, vol. 21, no. 8, pp. 1236–1239, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. A. I. Adler, H. A. W. Neil, S. E. Manley, R. R. Holman, and R. C. Turner, “Hyperglycemia and hyperinsulinemia at diagnosis of diabetes and their association with subsequent cardiovascular disease in the United Kingdom prospective diabetes study (UKPDS 47),” American Heart Journal, vol. 138, no. 5, pp. S353–S359, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. The DECODE Study Group, “Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. European diabetes epidemiology group. Diabetes epidemiology: collaborative analysis of diagnostic criteria in Europe,” The Lancet, vol. 354, no. 9179, pp. 617–621, 1999. View at Google Scholar
  13. D. M. Nathan, P. A. Cleary, J.-Y. C. Backlund et al., “Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes,” The New England Journal of Medicine, vol. 353, no. 25, pp. 2643–2653, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. E. L. M. Barr, P. Z. Zimmet, T. A. Welborn et al., “Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab),” Circulation, vol. 116, no. 2, pp. 151–157, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. National Diabetes Education Program, “Guiding principles for diabetes care: for health care professionals,” http://ndep.nih.gov/media/GuidPrin_HC_Eng.pdf.
  16. W. W. Eaton, H. Armenian, J. Gallo, L. Pratt, and D. E. Ford, “Depression and risk for onset of type II diabetes: a prospective population-based study,” Diabetes Care, vol. 19, no. 10, pp. 1097–1102, 1996. View at Publisher · View at Google Scholar · View at Scopus
  17. S. H. Golden, J. E. Williams, D. E. Ford et al., “Depressive symptoms and the risk of type 2 diabetes: the Atherosclerosis Risk in Communities study,” Diabetes Care, vol. 27, no. 2, pp. 429–435, 2004. View at Google Scholar
  18. S. H. Golden, M. Lazo, M. Carnethon et al., “Examining a bidirectional association between depressive symptoms and diabetes,” Journal of the American Medical Association, vol. 299, no. 23, pp. 2751–2759, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Engum, “The role of depression and anxiety in onset of diabetes in a large population-based study,” Journal of Psychosomatic Research, vol. 62, no. 1, pp. 31–38, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Campayo, P. De Jonge, J. F. Roy et al., “Depressive disorder and incident diabetes mellitus: the effect of characteristics of depression,” American Journal of Psychiatry, vol. 167, no. 5, pp. 580–588, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. L. C. Brown, S. R. Majumdar, S. C. Newman, and J. A. Johnson, “History of depression increases risk of type 2 diabetes in younger adults,” Diabetes Care, vol. 28, no. 5, pp. 1063–1067, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. M. van den Akker, A. Schuurman, J. Metsemakers, and F. Buntinx, “Is depression related to subsequent diabetes mellitus?” Acta Psychiatrica Scandinavica, vol. 110, no. 3, pp. 178–183, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. P.-C. Chen, Y.-T. Chan, H.-F. Chen, M.-C. Ko, and C.-Y. Li, “Population-based cohort analyses of the bidirectional relationship between type 2 diabetes and depression,” Diabetes Care, vol. 36, no. 2, pp. 376–382, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Garcia-Rizo, E. Fernandez-Egea, B. J. Miller et al., “Abnormal glucose tolerance, white blood cell count, and telomere length in newly diagnosed, antidepressant-naïve patients with depression,” Brain, Behavior, and Immunity, vol. 28, pp. 49–53, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. A.-K. Eriksson, A. Ekbom, F. Granath, A. Hilding, S. Efendic, and C.-G. Östenson, “Psychological distress and risk of pre-diabetes and type 2 diabetes in a prospective study of swedish middle-aged men and women,” Diabetic Medicine, vol. 25, no. 7, pp. 834–842, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. Centers for Disease Control and Prevention, “National health and nutrition examination survey, 2009-2010 data documentation, codebook, and frequencies,” http://www.cdc.gov/nchs/nhanes/nhanes2009-2010/DPQ_F.htm.
  27. K. Kroenke, R. L. Spitzer, and J. B. W. Williams, “The PHQ-9: validity of a brief depression severity measure,” Journal of General Internal Medicine, vol. 16, no. 9, pp. 606–613, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. R. L. Spitzer, K. Kroenke, and J. B. W. Williams, “Validation and utility of a self-report version of PRIME-MD: the PHQ Primary Care Study,” Journal of the American Medical Association, vol. 282, no. 18, pp. 1737–1744, 1999. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Rost and J. Smith, “Retooling multiple levels to improve primary care depression treatment,” Journal of General Internal Medicine, vol. 16, no. 9, pp. 644–645, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Kroenke and R. L. Spitzer, “The PHQ-9: a new depression diagnostic and severity measure,” Psychiatric Annals, vol. 32, no. 9, pp. 509–515, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Pinto-Meza, A. Serrano-Blanco, M. T. Peñarrubia, E. Blanco, and J. M. Haro, “Assessing depression in primary care with the PHQ-9: can it be carried out over the telephone?” Journal of General Internal Medicine, vol. 20, no. 8, pp. 738–742, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. D. J. Kupfer, E. A. Kuhl, and D. A. Regier, “Two views on the new DSM-5: DSM-5: a diagnostic guide relevant to both primary care and psychiatric practice,” American Family Physician, vol. 88, no. 8, 2013. View at Google Scholar
  33. Centers for Disease Control and Prevention (CDC), National Health and Nutrition Examination Survey 2009-2010 Data Documentation, Codebook, and Frequencies, Depression Screener (DPQ_F), 2013, http://www.cdc.gov/nchs/nhanes/nhanes2009-2010/DPQ_F.htm.
  34. Centers for Disease Control and Prevention, “Awareness of prediabetes—United States, 2005–2010,” Morbidity and Mortality Weekly Report, vol. 62, no. 11, pp. 209–212, 2013. View at Google Scholar
  35. Centers for Disease Control and Prevention, National Diabetes Prevention Program. Pre-Diabetes: Am I at risk?, March 2015, http://www.cdc.gov/diabetes/prevention/prediabetes.htm.
  36. International Diabetes Federation, Diabetes Risk Factors, 2014, http://www.idf.org/about-diabetes/risk-factors.
  37. The National Bureau of Economic Research, The Effects of Education on Health, The National Bureau of Economic Research, 2015, http://www.nber.org/digest/mar07/w12352.html.
  38. L. S. Goldman, L. H. Nielsen, H. C. Champion, and The Council on Scientific Affairs. American Medical Association, “Awareness, diagnosis, and treatment of depression,” Journal of General Internal Medicine, vol. 14, no. 9, pp. 569–580, 1999. View at Google Scholar
  39. American Diabetes Association [ADA], “Standards of medical care in diabetes—2012,” Diabetes Care, vol. 35, supplement 1, pp. S11–S63, 2011. View at Publisher · View at Google Scholar
  40. K. Shaw, M. Killeen, E. Sullivan, and P. Bowman, “Disparities in diabetes self-management education for uninsured and underinsured adults,” Diabetes Educator, vol. 37, no. 6, pp. 813–819, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. P. C. Conlon, “Diabetes outcomes in primary care: evaluation of the diabetes nurse practitioner compared to the physician,” Primary Health Care, vol. 20, no. 5, pp. 26–31, 2010. View at Publisher · View at Google Scholar
  42. J. H. Howse, S. Jones, and A. P. S. Hungin, “Screening for diabetes in optometry practices: acceptability to users,” Ophthalmic & Physiological Optics, vol. 31, no. 4, pp. 367–374, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. K. A. Snella, A. E. Canales, B. K. Irons et al., “Pharmacy- and community-based screenings for diabetes and cardiovascular conditions in high-risk individuals,” Journal of the American Pharmacists Association, vol. 46, no. 3, pp. 370–377, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. S. M. Strauss, M. C. Alfano, D. Shelley, and T. Fulmer, “Identifying unaddressed systemic health conditions at dental visits: patients who visited dental practices but not general health care providers in 2008,” American Journal of Public Health, vol. 102, no. 2, pp. 253–255, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. D. Holtzman, “The behavioral risk factor surveillance system,” in Community-Based Health Research: Issues and Methods, D. S. Blumenthal and R. J. DiClemente, Eds., Springer, New York, NY, USA, 2004. View at Google Scholar
  46. C. A. Okoro, T. W. Strine, P. I. Eke, S. S. Dhingra, and L. S. Balluz, “The association between depression and anxiety and use of oral health services and tooth loss,” Community Dentistry and Oral Epidemiology, vol. 40, no. 2, pp. 134–144, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. B. L. Greenberg, M. Glick, F.-H. Julie, and M. L. Kantor, “Dentists' attitudes toward chairside screening for medical conditions,” The Journal of the American Dental Association, vol. 141, no. 1, pp. 52–62, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. B. Laurence, “Dentists consider medical screening important and are willing to incorporate screening procedures into dental practice,” Journal of Evidence-Based Dental Practice, vol. 10, no. 4, pp. 254–256, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. M. T. Rosedale and S. M. Strauss, “Diabetes screening at the periodontal visit: patient and provider experiences with two screening approaches,” International Journal of Dental Hygiene, vol. 10, no. 4, pp. 250–258, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. S. M. Strauss, A. J. Wheeler, S. L. Russell et al., “The potential use of gingival crevicular blood for measuring glucose to screen for diabetes: an examination based on characteristics of the blood collection site,” Journal of Periodontology, vol. 80, no. 6, pp. 907–914, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. S. M. Strauss, J. Tuthill, G. Singh et al., “A novel intraoral diabetes screening approach in periodontal patients: results of a pilot study,” Journal of Periodontology, vol. 83, no. 6, pp. 699–706, 2012. View at Publisher · View at Google Scholar · View at Scopus
  52. I. F. Angelillo, C. G. Nobile, M. Pavia, P. de Fazio, M. Puca, and A. Amati, “Dental health and treatment needs in institutionalized psychiatric patients in Italy,” Community Dentistry and Oral Epidemiology, vol. 23, no. 6, pp. 360–364, 1995. View at Publisher · View at Google Scholar · View at Scopus
  53. B. Arroll, F. Goodyear-Smith, S. Crengle et al., “Validation of PHQ-2 and PHQ-9 to screen for major depression in the primary care population,” Annals of Family Medicine, vol. 8, no. 4, pp. 348–353, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. S. Gilbody, D. Richards, S. Brealey, and C. Hewitt, “Screening for depression in medical settings with the patient health questionnaire (PHQ): a diagnostic meta-analysis,” Journal of General Internal Medicine, vol. 22, no. 11, pp. 1596–1602, 2007. View at Publisher · View at Google Scholar · View at Scopus
  55. D. E. Nease Jr. and J. M. Malouin, “Depression screening: a practical strategy,” Journal of Family Practice, vol. 52, no. 2, pp. 118–124, 2003. View at Google Scholar · View at Scopus
  56. Finnish Diabetes Association, “Type 2 Diabetes Risk Assessment Form,” http://www.idf.org/webdata/docs/FINDRISC_English.pdf.
  57. American Diabetes Association, “Diabetes Risk Test,” http://www.diabetes.org/assets/pdfs/at-risk/risk-test-paper-version.pdf.